News
Patient groups, healthcare professionals and NHS England came together to take action to ensure people in hospital get their medication on time, every time.
We’re teaming up with Walking Football Scotland to give people with Parkinson's more opportunities to play the game.
The Prescription Charges Coalition have handed in a letter signed by over 600 people to freeze the charge at a time when costs are going up.
Foslevodopa-foscarbidopa (also called Produodopa) has been approved by NICE in England, Northern Ireland and Wales and the Scottish Medicines Consortium for people with Parkinson’s who experience movement related symptoms.
Foslevodopa-foscarbidopa (also called Produodopa) can be offered in England from 27 February for people with Parkinson’s who experience movement related symptoms.
Produodopa, a groundbreaking new treatment for advanced Parkinson’s, can now be prescribed in Scotland.
Friday 8 March is International Women's Day and Parkinson's UK is celebrating all the inspirational women who either help to deliver our physical activity programmes, or have become physical activity advocates with Parkinson's.
This week’s spring budget failed to offer much-needed support for people with Parkinson’s.
A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
At the end of March, the government’s cost of living support will come to an end. Yet our new research has found that for many people with Parkinson’s, the cost of living crisis is far from over.